Capturing B type acute lymphoblastic leukemia cells using two types of antibodies

Author:

İçöz Kutay12ORCID,Gerçek Tayyibe12,Murat Ayşegül3,Özcan Servet43,Ünal Ekrem5

Affiliation:

1. BioMINDS (Bio Micro/Nano Devices and Sensors) Lab, Dept. of Electrical and Electronics Engineering; Abdullah Gül University; Kayseri Turkey

2. Bioengineering Dept.; Abdullah Gül University; Kayseri Turkey

3. Genome and Stem Cell Center (GENKOK); Erciyes University; Kayseri Turkey

4. Biology Dept.; Erciyes University; Kayseri Turkey

5. Pediatric Oncology Dept.; Erciyes University; Kayseri Turkey

Funder

Scientific and Technological Research Council of Turkey

Publisher

Wiley

Subject

Biotechnology

Reference43 articles.

1. Treatment of acute lymphoblastic leukemia;Pui;N Engl J Med,2006

2. Minimal residual disease monitoring: the new standard for treatment evaluation of haematological malignancies?;Hauwel;Swiss Med Wkly,2014

3. Risk of relapse of childhood acute lymphoblastic leukemia is predicted by flow cytometric measurement of residual disease on day 15 bone marrow;Basso;J Clin Oncol,2009

4. Detection of minimal residual disease in pediatric acute lymphoblastic leukemia;Gaipa;Cytom Part B Clin Cytom,2013

5. Advances in the immunological monitoring of childhood acute lymphoblastic leukaemia;Campana;Best Pract Res Clin Haematol,2002

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3